nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100A1—adrenal cortex—polycystic ovary syndrome	0.0266	0.0567	CbGeAlD
Olopatadine—S100A1—endometrium—polycystic ovary syndrome	0.0238	0.0506	CbGeAlD
Olopatadine—S100A2—pituitary gland—polycystic ovary syndrome	0.0234	0.0498	CbGeAlD
Olopatadine—S100A2—adipose tissue—polycystic ovary syndrome	0.0233	0.0496	CbGeAlD
Olopatadine—S100A1—pituitary gland—polycystic ovary syndrome	0.0215	0.0458	CbGeAlD
Olopatadine—S100A1—adipose tissue—polycystic ovary syndrome	0.0214	0.0456	CbGeAlD
Olopatadine—S100A2—female gonad—polycystic ovary syndrome	0.0195	0.0415	CbGeAlD
Olopatadine—S100A2—vagina—polycystic ovary syndrome	0.0193	0.0412	CbGeAlD
Olopatadine—S100A1—adrenal gland—polycystic ovary syndrome	0.0192	0.0409	CbGeAlD
Olopatadine—S100A13—adipose tissue—polycystic ovary syndrome	0.019	0.0405	CbGeAlD
Olopatadine—S100A12—pituitary gland—polycystic ovary syndrome	0.0188	0.0401	CbGeAlD
Olopatadine—S100A12—adipose tissue—polycystic ovary syndrome	0.0188	0.0399	CbGeAlD
Olopatadine—S100B—adipose tissue—polycystic ovary syndrome	0.0185	0.0394	CbGeAlD
Olopatadine—S100A2—endocrine gland—polycystic ovary syndrome	0.0181	0.0385	CbGeAlD
Olopatadine—S100A13—adrenal gland—polycystic ovary syndrome	0.0171	0.0363	CbGeAlD
Olopatadine—S100A12—adrenal gland—polycystic ovary syndrome	0.0168	0.0358	CbGeAlD
Olopatadine—S100A1—endocrine gland—polycystic ovary syndrome	0.0167	0.0355	CbGeAlD
Olopatadine—S100A13—female gonad—polycystic ovary syndrome	0.0159	0.0339	CbGeAlD
Olopatadine—S100A12—female gonad—polycystic ovary syndrome	0.0157	0.0334	CbGeAlD
Olopatadine—S100A12—vagina—polycystic ovary syndrome	0.0156	0.0332	CbGeAlD
Olopatadine—S100A13—endocrine gland—polycystic ovary syndrome	0.0148	0.0315	CbGeAlD
Olopatadine—S100A12—endocrine gland—polycystic ovary syndrome	0.0146	0.0311	CbGeAlD
Olopatadine—S100B—endocrine gland—polycystic ovary syndrome	0.0144	0.0307	CbGeAlD
Olopatadine—CYP3A4—urine—polycystic ovary syndrome	0.0138	0.0293	CbGeAlD
Olopatadine—HRH1—endometrium—polycystic ovary syndrome	0.00421	0.00897	CbGeAlD
Olopatadine—HRH1—adipose tissue—polycystic ovary syndrome	0.0038	0.00809	CbGeAlD
Olopatadine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.00362	0.116	CrCbGaD
Olopatadine—HRH1—adrenal gland—polycystic ovary syndrome	0.00341	0.00725	CbGeAlD
Olopatadine—HRH1—female gonad—polycystic ovary syndrome	0.00317	0.00676	CbGeAlD
Olopatadine—HRH1—vagina—polycystic ovary syndrome	0.00316	0.00672	CbGeAlD
Olopatadine—Nortriptyline—ADRA1D—polycystic ovary syndrome	0.00315	0.101	CrCbGaD
Olopatadine—HRH1—endocrine gland—polycystic ovary syndrome	0.00295	0.00629	CbGeAlD
Olopatadine—Doxepin—ADRA1D—polycystic ovary syndrome	0.00283	0.0906	CrCbGaD
Olopatadine—Nortriptyline—ADRA1B—polycystic ovary syndrome	0.00269	0.0861	CrCbGaD
Olopatadine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.00244	0.078	CrCbGaD
Olopatadine—Doxepin—ADRA1B—polycystic ovary syndrome	0.00241	0.0773	CrCbGaD
Olopatadine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00228	0.00486	CbGeAlD
Olopatadine—Imipramine—ADRA1D—polycystic ovary syndrome	0.0022	0.0705	CrCbGaD
Olopatadine—Amitriptyline—ADRA1D—polycystic ovary syndrome	0.00219	0.07	CrCbGaD
Olopatadine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00188	0.0601	CrCbGaD
Olopatadine—Amitriptyline—ADRA1B—polycystic ovary syndrome	0.00186	0.0598	CrCbGaD
Olopatadine—Nortriptyline—ADRA1A—polycystic ovary syndrome	0.00181	0.058	CrCbGaD
Olopatadine—Doxepin—ADRA1A—polycystic ovary syndrome	0.00162	0.052	CrCbGaD
Olopatadine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00144	0.0457	CcSEcCtD
Olopatadine—Influenza—Metformin—polycystic ovary syndrome	0.00139	0.0441	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00129	0.041	CcSEcCtD
Olopatadine—Imipramine—ADRA1A—polycystic ovary syndrome	0.00126	0.0405	CrCbGaD
Olopatadine—Amitriptyline—ADRA1A—polycystic ovary syndrome	0.00126	0.0402	CrCbGaD
Olopatadine—Infestation NOS—Metformin—polycystic ovary syndrome	0.00124	0.0393	CcSEcCtD
Olopatadine—Infestation—Metformin—polycystic ovary syndrome	0.00124	0.0393	CcSEcCtD
Olopatadine—Rhinitis—Metformin—polycystic ovary syndrome	0.00111	0.0354	CcSEcCtD
Olopatadine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00111	0.0351	CcSEcCtD
Olopatadine—Eye disorder—Metformin—polycystic ovary syndrome	0.00104	0.033	CcSEcCtD
Olopatadine—Immune system disorder—Metformin—polycystic ovary syndrome	0.001	0.0319	CcSEcCtD
Olopatadine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.001	0.0318	CcSEcCtD
Olopatadine—Erythema—Metformin—polycystic ovary syndrome	0.000967	0.0307	CcSEcCtD
Olopatadine—Dysgeusia—Metformin—polycystic ovary syndrome	0.000947	0.0301	CcSEcCtD
Olopatadine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00093	0.0296	CcSEcCtD
Olopatadine—Vision blurred—Metformin—polycystic ovary syndrome	0.000912	0.029	CcSEcCtD
Olopatadine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000898	0.0285	CcSEcCtD
Olopatadine—Malaise—Metformin—polycystic ovary syndrome	0.000872	0.0277	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000818	0.026	CcSEcCtD
Olopatadine—Discomfort—Metformin—polycystic ovary syndrome	0.000814	0.0259	CcSEcCtD
Olopatadine—Oedema—Metformin—polycystic ovary syndrome	0.00079	0.0251	CcSEcCtD
Olopatadine—Infection—Metformin—polycystic ovary syndrome	0.000784	0.0249	CcSEcCtD
Olopatadine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000774	0.0246	CcSEcCtD
Olopatadine—Skin disorder—Metformin—polycystic ovary syndrome	0.000767	0.0244	CcSEcCtD
Olopatadine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000704	0.0224	CcSEcCtD
Olopatadine—Somnolence—Metformin—polycystic ovary syndrome	0.000702	0.0223	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000682	0.0217	CcSEcCtD
Olopatadine—Fatigue—Metformin—polycystic ovary syndrome	0.000681	0.0216	CcSEcCtD
Olopatadine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000651	0.0207	CcSEcCtD
Olopatadine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000646	0.0205	CcSEcCtD
Olopatadine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000624	0.0198	CcSEcCtD
Olopatadine—Asthenia—Metformin—polycystic ovary syndrome	0.000567	0.018	CcSEcCtD
Olopatadine—Pruritus—Metformin—polycystic ovary syndrome	0.000559	0.0178	CcSEcCtD
Olopatadine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00054	0.0172	CcSEcCtD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000527	0.00113	CbGpPWpGaD
Olopatadine—S100B—Immune System—GAB1—polycystic ovary syndrome	0.000525	0.00112	CbGpPWpGaD
Olopatadine—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000523	0.00112	CbGpPWpGaD
Olopatadine—Dizziness—Metformin—polycystic ovary syndrome	0.000522	0.0166	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000518	0.00111	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—polycystic ovary syndrome	0.000514	0.0011	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000511	0.00109	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00051	0.00109	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CAMK2D—polycystic ovary syndrome	0.000504	0.00108	CbGpPWpGaD
Olopatadine—Vomiting—Metformin—polycystic ovary syndrome	0.000502	0.016	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.0005	0.00107	CbGpPWpGaD
Olopatadine—Rash—Metformin—polycystic ovary syndrome	0.000498	0.0158	CcSEcCtD
Olopatadine—Dermatitis—Metformin—polycystic ovary syndrome	0.000497	0.0158	CcSEcCtD
Olopatadine—S100A12—Immune System—TNRC6B—polycystic ovary syndrome	0.000496	0.00106	CbGpPWpGaD
Olopatadine—Headache—Metformin—polycystic ovary syndrome	0.000495	0.0157	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000486	0.00104	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—IL6—polycystic ovary syndrome	0.000484	0.00103	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IRS2—polycystic ovary syndrome	0.000482	0.00103	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CRP—polycystic ovary syndrome	0.000482	0.00103	CbGpPWpGaD
Olopatadine—S100B—Immune System—CAMK2D—polycystic ovary syndrome	0.000477	0.00102	CbGpPWpGaD
Olopatadine—S100B—Immune System—TNRC6B—polycystic ovary syndrome	0.000469	0.001	CbGpPWpGaD
Olopatadine—Nausea—Metformin—polycystic ovary syndrome	0.000469	0.0149	CcSEcCtD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000466	0.000996	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000457	0.000977	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000457	0.000977	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.000456	0.000975	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IRS2—polycystic ovary syndrome	0.000456	0.000974	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CRP—polycystic ovary syndrome	0.000456	0.000974	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000448	0.000957	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000444	0.00095	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ATF1—polycystic ovary syndrome	0.000436	0.000931	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FST—polycystic ovary syndrome	0.000433	0.000926	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000433	0.000926	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000428	0.000914	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000423	0.000904	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000423	0.000904	CbGpPWpGaD
Olopatadine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000422	0.000901	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IRS1—polycystic ovary syndrome	0.000421	0.000899	CbGpPWpGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000417	0.000892	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000414	0.000885	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000413	0.000883	CbGpPWpGaD
Olopatadine—S100B—Immune System—ATF1—polycystic ovary syndrome	0.000412	0.00088	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000409	0.000875	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000406	0.000867	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TAB1—polycystic ovary syndrome	0.000402	0.000859	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.0004	0.000855	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PRL—polycystic ovary syndrome	0.000398	0.000851	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IRS1—polycystic ovary syndrome	0.000398	0.00085	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000396	0.000847	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000394	0.000842	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000389	0.000832	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—AKT2—polycystic ovary syndrome	0.000389	0.000832	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000381	0.000814	CbGpPWpGaD
Olopatadine—S100B—Immune System—TAB1—polycystic ovary syndrome	0.00038	0.000812	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000378	0.000808	CbGpPWpGaD
Olopatadine—S100B—Immune System—PRL—polycystic ovary syndrome	0.000377	0.000805	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000376	0.000804	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000375	0.000801	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000371	0.000794	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000368	0.000787	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—AKT2—polycystic ovary syndrome	0.000368	0.000787	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000367	0.000784	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000367	0.000784	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000365	0.00078	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000348	0.000744	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000346	0.000739	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000346	0.000739	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000344	0.000735	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000343	0.000733	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000341	0.000728	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00034	0.000727	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—BCL2—polycystic ovary syndrome	0.00034	0.000727	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000339	0.000725	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000338	0.000722	CbGpPWpGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000336	0.000719	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL18—polycystic ovary syndrome	0.000335	0.000716	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NRG1—polycystic ovary syndrome	0.000328	0.0007	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000326	0.000697	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000324	0.000693	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000323	0.000691	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—BCL2—polycystic ovary syndrome	0.000322	0.000687	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL18—polycystic ovary syndrome	0.000317	0.000677	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000314	0.000671	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000314	0.000671	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000314	0.000671	CbGpPWpGaD
Olopatadine—S100B—Immune System—NRG1—polycystic ovary syndrome	0.00031	0.000662	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000308	0.000658	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000305	0.000653	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000303	0.000648	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PGR—polycystic ovary syndrome	0.0003	0.000642	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000299	0.00064	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000294	0.000628	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000285	0.000609	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IRS2—polycystic ovary syndrome	0.000281	0.0006	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CRP—polycystic ovary syndrome	0.000281	0.0006	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00028	0.000597	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000279	0.000597	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000279	0.000597	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000279	0.000597	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000278	0.000594	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000277	0.000593	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000276	0.000591	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000276	0.000589	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000266	0.000569	CbGpPWpGaD
Olopatadine—S100B—Immune System—IRS2—polycystic ovary syndrome	0.000265	0.000567	CbGpPWpGaD
Olopatadine—S100B—Immune System—CRP—polycystic ovary syndrome	0.000265	0.000567	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00026	0.000555	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000257	0.00055	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000254	0.000543	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000254	0.000543	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000253	0.000541	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000252	0.000539	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000247	0.000529	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000246	0.000525	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IRS1—polycystic ovary syndrome	0.000245	0.000524	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000244	0.000522	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000244	0.000521	CbGpPWpGaD
Olopatadine—S100B—Immune System—IRS1—polycystic ovary syndrome	0.000232	0.000495	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000231	0.000495	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000231	0.000494	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000231	0.000493	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00023	0.000492	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00023	0.000491	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000227	0.000485	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT2—polycystic ovary syndrome	0.000227	0.000485	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000223	0.000476	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000222	0.000475	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00022	0.00047	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000215	0.00046	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT2—polycystic ovary syndrome	0.000214	0.000458	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000214	0.000458	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000213	0.000455	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00021	0.000449	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000206	0.000441	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000206	0.00044	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000204	0.000436	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000202	0.000432	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000201	0.000429	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.0002	0.000428	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.0002	0.000427	CbGpPWpGaD
Olopatadine—S100A12—Immune System—BCL2—polycystic ovary syndrome	0.000198	0.000423	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000197	0.000422	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000197	0.000421	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000195	0.000418	CbGpPWpGaD
Olopatadine—S100B—Immune System—BCL2—polycystic ovary syndrome	0.000187	0.0004	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000187	0.0004	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000185	0.000396	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000185	0.000396	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000182	0.000389	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00018	0.000384	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000179	0.000382	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—polycystic ovary syndrome	0.000176	0.000376	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000175	0.000373	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000173	0.000371	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000172	0.000367	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000168	0.00036	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LEP—polycystic ovary syndrome	0.000168	0.000359	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—polycystic ovary syndrome	0.000166	0.000356	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000164	0.00035	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00016	0.000341	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00015	0.00032	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000149	0.000319	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000147	0.000314	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000145	0.000311	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000145	0.000309	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—POMC—polycystic ovary syndrome	0.000144	0.000308	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—INS—polycystic ovary syndrome	0.000143	0.000307	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000139	0.000297	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000139	0.000296	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000136	0.00029	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000133	0.000284	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000132	0.000282	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000132	0.000282	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000129	0.000276	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000128	0.000273	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000124	0.000265	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000121	0.000259	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00012	0.000257	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000119	0.000255	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000118	0.000252	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000118	0.000252	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000118	0.000252	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000115	0.000247	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000112	0.000239	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000112	0.000238	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000111	0.000236	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00011	0.000235	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000109	0.000234	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000109	0.000233	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000106	0.000226	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000104	0.000222	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000103	0.00022	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—polycystic ovary syndrome	0.000103	0.000219	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000102	0.000219	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000101	0.000216	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—polycystic ovary syndrome	9.7e-05	0.000207	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	9.6e-05	0.000205	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	9.47e-05	0.000202	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	9.33e-05	0.000199	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	9.33e-05	0.000199	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.06e-05	0.000194	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	9.06e-05	0.000194	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	8.6e-05	0.000184	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	8.47e-05	0.000181	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	8.39e-05	0.000179	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.82e-05	0.000167	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	7.8e-05	0.000167	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	7.8e-05	0.000167	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.51e-05	0.000161	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	7.44e-05	0.000159	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	7.42e-05	0.000158	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.25e-05	0.000155	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.22e-05	0.000154	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	7.07e-05	0.000151	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	6.86e-05	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	6.82e-05	0.000146	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	6.8e-05	0.000145	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.56e-05	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.45e-05	0.000138	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	6.3e-05	0.000135	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—polycystic ovary syndrome	6.27e-05	0.000134	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	6.01e-05	0.000129	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	5.98e-05	0.000128	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.7e-05	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	5.59e-05	0.00012	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.49e-05	0.000117	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.36e-05	0.000115	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.19e-05	0.000111	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.79e-05	0.000102	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.78e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	4.69e-05	0.0001	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.63e-05	9.89e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.46e-05	9.53e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.29e-05	9.16e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.23e-05	9.05e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.18e-05	8.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	4.03e-05	8.61e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	4.01e-05	8.56e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4e-05	8.54e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.93e-05	8.41e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.88e-05	8.28e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.87e-05	8.28e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.68e-05	7.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.4e-05	7.28e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.31e-05	7.08e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.11e-05	6.66e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.96e-05	6.33e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.78e-05	5.94e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.65e-05	5.66e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.53e-05	5.41e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.51e-05	5.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.34e-05	5e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.9e-05	4.06e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.87e-05	4e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.86e-05	3.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	1.75e-05	3.74e-05	CbGpPWpGaD
